Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: In vitro - In vivo studies

BMC Nuclear Medicine

Volumn 5, Issue , 2005, Pages

  Terán, Mariella ^a   Savio, Eduardo ^a   Paolino, Andrea ^a   Frier, Malcolm ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN PENTETATE TECHNETIUM TC 99M; CYSTEINE ETHYL ESTER TC 99M; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TRACER;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMALE; HUMAN; HYDROPHILICITY; KINETICS; LIPOPHILICITY; MALE; NORMAL HUMAN; PH; PHYSICAL CHEMISTRY; SCINTIGRAPHY; STATISTICAL ANALYSIS;

EID: 27744443603     PISSN: 14712385     EISSN: 14712385     Source Type: Journal    
DOI: 10.1186/1471-2385-5-5     Document Type: Article

References (27)

1. Wilson CG, Perkins AC: Gamma Scintigraphy and the study of drug deposition. Advances in pharmaceutical sciences. London Academic Press; 1992.
2. Alan Perkins, Malcolm Frier: Nuclear Medicine in Pharmaceutical Research. London Taylor and Francis; 1999.
3. Wilson CG: Washington N. Chichester. In Physiological Pharmaceutics: Biological Barriers to Drug Absorption London Ellis Horwood; 1989.
4. Budisantoso N, Frier M, Wilson CG: Lipophilic models for scintigraphic evaluation of drug delivery systems. J Pharmacy and Pharmacology 1997, 49(4):49.
5. Adkin DA, Davis SS, Sparrow RA, Huckle PD, Phillips AJ, Wilding IR: The effects of pharmaceutical excipients on small intestinal transit. Br J Clin Pharmac 1995, 39:381-387.
6. Wood E, Wilson CG, Hardy JG: The spreading of foam and solution enemas. Int J Pharm 1985, 25:191-197.
7. Newman SP, Woodman G, Clarke SW: Deposition of carbenicillin aerosols in cystic fibrosis; efects of nebuliser system and breathing pattern. Thorax 1988, 43:318-322.
8. 99mTc-DTPA and delivered by novel system (AER) in healthy subjects. Eur J Nucl Med 1999, 26:4.
9. Bartlett RJV, Perkins A, Ware FW, Riley A, Robinson PJA: Reproducibility of oesophageal transit studies: several single swallows must be performed. Nucl Med Commun 1987, 8:317-326.
10. Hardy JG: Radiopharmaceuticals: using radioactive compounds in pharmaceutics and medicine. Radionucleide imaging in drug formulation. London Ellis Horwood Limited; 1989.
11. Dams TTM, Cortens H: Lessons for medicine and nuclear medicine research. Eur J Nucl Med 1999, 26:311-313.
12. Newman SP, Wilding IR: Imaging techniques for assessing drug delivery in man. Pharm Sci Technol Today 1999, 2:181-189.
13. Davies SS, Hardy JG, Newman SP, Wilding IR: Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Review article. European Journal of Nuclear Medicine 1992, 19:971-986.
14. Perkins AC, Frier M: Nuclear medicine techniques in the evaluation of pharmaceutical formulations. Pharmacy World and Science 1996, 18:97-104.
15. Early PJ, Sodee DB: Principles and Practice of Nuclear Medicine. Second edition. USA. Mosby -Year Book Inc; 1995:94-117.
16. Jurisson S, Berning D, Wei Jia , Dangshe Ma : Coordination compounds in Nuclear Medicine. Chemical Reviews 1993, 3:1137-1156. l93
17. Terán M, Paolino A, Savio E, Gaudiano JP, León AS, Frier M: Centellografía en el desarrollo farmacéutico: Estudios in vitro e in vivo de comprimidos de ranitidina. Acta Farmacéutica Bonaerense 2000, 19(3):217-224.
18. 99mTc-ECD. European Journal of Pharmaceutics and Biopharmaceutics 2004, 57:347-352.
19. Donald Burns H, Raymond Gibson E, Robert Dannals , Peter KS: Nuclear Imaging in Drug Discovery, Development and Approval. Siegl Birkhäuser- Boston; 1993.
20. David Ganderton : Advances in Pharmaceutical Sciences. Academic Press London, England; 1992.
21. Wilding IR: Using product visualization techniques to characterize dosage form performance in man. British Pharmaceutical Conference Abstract Book 2001:306.
22. Wilson CG, Mc Jury M, O'Mahoy B, Frier M, Perkins AC: Imaging of oily formulations in the gastrointestinal tract. Advanced Drug Delivery Reviews 1997, 25:91-101.
23. Perkins AC, Mann C, Wilson CG: Three dimensional visualisation of the large bowel: A potential tool for assessing targeted drug delivery and colonic pathology. Eur J Nucl Med 1995, 22:1035-1038.
24. Perkis AC, et al.: Oesophageal transit, disintegration and gastric empting of a film - coated resindronate placebo tablet in gastro - oesophageal reflux disease and normal control subjects. Aliment Pharmacol Ther 2001, 15:115-121.
25. Perkins AC, et al.: Esophageal transit of risedronate cellulose - coated tablet and gelatin capsule formulations. International Journal of Pharmaceutics 1999, 186:169-175.
26. Cid Cárcamo E: Control de calidad biofarmacéutico de medicamentos. Ed Churcill Livingstone Spain; 1993.
27. Donald L: Smith Probability, Statistics and Data Uncertainties in Nuclear Science and Technology. American Nuclear Society Volume 4. LaGrange Park, Illinois, USA; 1991.